Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Quanterix Corporation - Common Stock (NQ:QTRX)

5.860 +0.110 (+1.91%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 23, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Quanterix Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
A Preview Of Quanterix's Earnings
 
Via Benzinga
Quanterix to Report Third Quarter 2023 Financial Results on November 7, 2023
From Quanterix Corporation
Via Business Wire
Quanterix Launches High Accuracy p-Tau 217 Blood Biomarker Test to Aid Physician Diagnosis of Alzheimer’s Disease
From Quanterix Corporation
Via Business Wire
Quanterix Announces New Agreement to Advance Blood Based Alzheimer's Disease Detection
From Quanterix Corporation
Via Business Wire
Analyst Expectations for Quanterix's Future
 
Via Benzinga
Quanterix Corp. (NASDAQ: QTRX) is a Stock Spotlight on 9/1
Via Investor Brand Network
Quanterix Corp. (NASDAQ: QTRX) is a Stock Spotlight on 8/21
Via Investor Brand Network
Quanterix CEO to Speak at Goldman Sachs Alzheimer’s Disease Day
From Quanterix Corporation
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For September 25, 2023
 
Via Benzinga
Quanterix Corp. (NASDAQ: QTRX) is a Stock Spotlight on 8/16
Via Investor Brand Network
Quanterix Corp. (NASDAQ: QTRX) is a Stock Spotlight on 8/8
Via Investor Brand Network
Quanterix to Participate at the Morgan Stanley 21st Annual Global Healthcare Conference
From Quanterix Corporation
Via Business Wire
William P. Donnelly Appointed to Quanterix’s Board of Directors
From Quanterix Corporation
Via Business Wire
Quanterix Appoints Vandana Sriram as Chief Financial Officer
From Quanterix Corporation
Via Business Wire
Recap: Quanterix Q1 Earnings
 
Via Benzinga
Quanterix's Return On Capital Employed Insights
 
Via Benzinga
Why Energizer Holdings Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers Nuburu, Inc. (NYSE: BURU) shares jumped 185.6% to $1.6593 after the company announced contract with NASA to demonstrate feasibility of power beaming in space using the company’s blue laser... 
Via Benzinga
Fox, Warner Music, Eli Lilly, Chegg And Other Big Stocks Moving Higher On Tuesday
U.S. stocks traded lower, with the Dow Jones falling around 400 points on Tuesday. Here are some big stocks recording gains in today’s session. Paymentus Holdings, Inc. (NYSE: PAY) shares rose 29.4% to... 
Via Benzinga
Quanterix Releases Operating Results for Second Quarter 2023
From Quanterix Corporation
Via Business Wire
Quanterix to Present at Canaccord Genuity 43rd Annual Growth Conference
From Quanterix Corporation
Via Business Wire
Quanterix’s Simoa® Technology Powers Large, International Reference Range Study Utilizing Serum Neurofilament Light (sNfL) to Assess Neurological Disease Activity in Pediatric Patients
From Quanterix Corporation
Via Business Wire
Quanterix to Report Second Quarter 2023 Financial Results on August 8, 2023
From Quanterix Corporation
Via Business Wire
Quanterix Launches LucentAD Biomarker Blood Test to Aid Physician Diagnosis of Alzheimer’s Disease in Patients
From Quanterix Corporation
Via Business Wire
Quanterix to Participate in Fireside Chat at Goldman Sachs Annual Global Healthcare Conference
From Quanterix Corporation
Via Business Wire
Why CohBar Shares Are Trading Lower By 161%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers 
Via Benzinga
Goldman Sachs Turns Bullish On Biotech With 'Significant Opportunity'
Shares of Quanterix Corp (NASDAQ: QTRX) spiked in early trading on Tuesday and the stock is up almost 75% year to date. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 23, 2023
 
Via Benzinga
Quanterix Releases Operating Results for First Quarter 2023
From Quanterix Corporation
Via Business Wire
Quanterix’s First Quarter 2023 Earnings Conference Call
From Quanterix Corporation
Via Business Wire
FDA Accelerated Approval of Tofersen Highlights Importance of Blood Neurofilament Light Chain as Surrogate Endpoint in Neurology Therapeutic Trials
From Quanterix Corporation
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.